Vaxcyte, Inc. PCVX Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s common stock shares issued?
- Vaxcyte, Inc. (PCVX) reported common stock shares issued of 144.3M in Q1 2026.
- How has Vaxcyte, Inc.'s common stock shares issued changed year-over-year?
- Vaxcyte, Inc.'s common stock shares issued increased by 11.9% year-over-year, from 128.9M to 144.3M.
- What is the long-term trend for Vaxcyte, Inc.'s common stock shares issued?
- Over 2 years (2023 to 2025), Vaxcyte, Inc.'s common stock shares issued has grown at a 17.2% compound annual growth rate (CAGR), from 95.4M to 131.1M.
- What does common stock shares issued mean?
- The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.